Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dutch State Sells Intravacc B.V. | Contract Pharma

What are you searching for?

Sign in
Breaking News

Dutch State Sells Intravacc B.V.

Intravacc is an established independent CDMO for infectious diseases and therapeutic vaccines.

By: Anthony Vecchione

The State of the Netherlands, the Dutch Ministry of Health, Welfare and Sport aims to sell 100% of the issued and outstanding shares in the capital of Intravacc B.V. through a controlled auction process. 
 
Intravacc is an established independent contract development and manufacturing organization (CDMO) for infectious diseases and therapeutic vaccines.

As a CDMO with many years of experience in the development and optimization of vaccines and vaccine technologies, Intravacc has transferred its technology world-wide for many vaccines, including polio, measles, DTP, Hib, and influenza.

Intravacc offers a wide range of expertise for independent vaccine development, from proof-of-concept to Phase I/II clinical studies for partners around the world, including universities, public health organizations, biotech, and pharmaceutical companies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics